Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
03/03/1994 | WO1994004690A1 Bispecific immunoadhesins |
03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
03/03/1994 | WO1994004685A1 Recombinant antigens and vaccines of bovine ephemeral fever virus |
03/03/1994 | WO1994004683A1 Bordetella bronchiseptica vaccine |
03/03/1994 | WO1994004680A1 Human interleukin-13 |
03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
03/03/1994 | WO1994004676A1 Stress protein epitopes |
03/03/1994 | WO1994004662A1 Papillomavirus: biosynthetic process and assays |
03/03/1994 | WO1994004661A1 Virus obtainable from human neuroblastoma cells |
03/03/1994 | WO1994004565A2 Ipnv vaccine |
03/03/1994 | WO1994004564A1 T cell epitopes of ryegrass pollen allergen |
03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
03/03/1994 | WO1994004552A1 Opioid receptor genes |
03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
03/03/1994 | WO1994004196A1 Tumour therapy |
03/03/1994 | WO1994004195A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
03/03/1994 | WO1994004188A1 Method for treating an lfa-1-mediated disorder |
03/03/1994 | WO1994004187A1 Method for improving the growth and the quality of carcases of domestic meat-producer animals, vaccination kit et vaccines |
03/03/1994 | WO1994004186A1 Homeopathic compositions for the treatment of viral and metabolic diseases |
03/03/1994 | WO1994004185A2 Method of inhibiting reduction of disulfide bonds |
03/03/1994 | WO1994004180A2 Novel uses of il-4 and/or il-10, and antibodies against the same |
03/03/1994 | WO1994004174A1 Cytokine applications |
03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
03/03/1994 | WO1994004121A1 Bystander suppression of retroviral-associated neurological disease |
03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
03/03/1994 | DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates |
03/03/1994 | CA2393847A1 Immunoglobulins devoid of light chains |
03/03/1994 | CA2142902A1 Virus obtainable from human neuroblastoma cells |
03/03/1994 | CA2142884A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
03/03/1994 | CA2142872A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |
03/03/1994 | CA2142863A1 Homeopatic compositions for the treatment of viral and metabolic diseases |
03/03/1994 | CA2142860A1 Human interleukin-13 |
03/03/1994 | CA2142469A1 Papillomavirus: biosynthetic process and assays |
03/03/1994 | CA2142305A1 Opioid receptor genes |
03/03/1994 | CA2141457A1 Cytokine applications |
03/03/1994 | CA2140933A1 Method for treating an lfa-1 mediated disorder |
03/03/1994 | CA2140280A1 Bispecific immunoadhesins |
03/03/1994 | CA2104976A1 Separation of plasma or serum from whole blood using a red blood cell binding component and a polymer containing multiple cationic sites |
03/02/1994 | EP0584767A1 Rapid extraction and neutralization of streptococcal antigen |
03/02/1994 | EP0584715A2 Isolation and culturing of transformed cells and preparation of antibodies against them |
03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
03/02/1994 | EP0584421A1 Immunoglobulins devoid of light chains |
03/02/1994 | EP0584348A1 Genetic vaccine for immunodeficiency viruses |
03/02/1994 | EP0584284A1 Recombinant dna-derived cholera toxin subunit analogs |
03/02/1994 | EP0584279A1 Targeted delivery of genes encoding immunogenic proteins |
03/02/1994 | EP0584273A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
03/02/1994 | EP0584212A1 Liposomal polysaccharide vaccines |
03/02/1994 | EP0584201A1 Transmission-blocking vaccine against malaria |
03/02/1994 | EP0584175A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
03/02/1994 | EP0584167A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
03/02/1994 | EP0584082A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
03/02/1994 | EP0470980B1 Synthetic peptides for an hiv-1 vaccine |
03/02/1994 | EP0391896B1 Enhanced uptake drug delivery system |
03/02/1994 | EP0371998B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
03/02/1994 | EP0347433B1 Recombinant antibody |
03/02/1994 | EP0266419B1 Fibrinolytic composition |
03/02/1994 | CN1082923A Process for attenuated varicella zoster virus vaccine production |
03/01/1994 | US5290688 Preparation of exoantigens and vaccine for cattle |
03/01/1994 | US5290681 Method of assaying immunization stimulating activity |
03/01/1994 | US5290571 Undenatured whey protein providing Vitamins B1 and B2 |
03/01/1994 | US5290563 Method for combining a mixture of heterogeneous substances with liposomes |
03/01/1994 | US5290551 Anticarcinogenic agents, immunology |
03/01/1994 | US5290540 Administering, in small particle aerosol form, an anti-inflammatory agent of a corticosteroid, indomethacin, ibuprofen or acetylsalicylic acid and an anti-infectious agent |
03/01/1994 | CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production |
03/01/1994 | CA2104997A1 Bone-related cadherin-like protein and process for its production |
03/01/1994 | CA2104995A1 Bone-related sulfatase-like protein and process for its production |
03/01/1994 | CA1327332C Animal derived cell with antigenic protein introduced therein |
03/01/1994 | CA1327331C Vaccines |
03/01/1994 | CA1327329C Recombinant diphtheria toxin fragments |
03/01/1994 | CA1327313C Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants |
02/27/1994 | CA2104244A1 Rapid extraction and neutralization of streptococcal antigen |
02/23/1994 | EP0584023A1 Mycobacteria DNA fragments, amplification primers, hybridization probes, reagents and detection process of mycobacteria |
02/23/1994 | EP0583998A1 Avirulent antirabies vaccine |
02/23/1994 | EP0583799A1 Monoclonal antibodies to ELAM-1 sialoglycoprotein antigen on the surface of activated endothelial cells |
02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
02/23/1994 | EP0583356A1 A method for treating infectious respiratory diseases |
02/23/1994 | CN1082606A Genetically engineered attenuated viruses |
02/22/1994 | US5288854 Antiinflammatory agents |
02/22/1994 | US5288845 Eimeria necatrix 16s rDNA probes |
02/22/1994 | US5288639 Purified candidal stress protein or immunogenic epitope or homolog thereof |
02/22/1994 | US5288630 For preparing specific immune responses against human respiratory syncytial virus |
02/22/1994 | US5288617 Method of producing an antigenic preparation |
02/22/1994 | US5288615 Methods for preparing proteins of altered structure |
02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
02/22/1994 | US5288502 Drug delivery |
02/22/1994 | CA1327168C Anti-trichomonas vaginalis monoclonal antibodies |
02/22/1994 | CA1327162C Method for prophylactically treating an individual for an autoimmune disease |
02/17/1994 | WO1994003813A1 Immunoassay for detecting collagen or collagen fragments |
02/17/1994 | WO1994003810A1 Method for detecting mycoplasmic infections |
02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
02/17/1994 | WO1994003628A1 Recombinant equine herpesviruses |
02/17/1994 | WO1994003621A1 Vector vaccines of recombinant feline herpesvirus |
02/17/1994 | WO1994003620A2 Method of increasing expression of viral proteins |
02/17/1994 | WO1994003615A1 Expression of recombinant fusion proteins in attenuated bacteria |